Skip to content
inentertainment.co.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
RenovoRx, Inc.
RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
April 1, 2026
RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update
March 30, 2026
RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment
March 26, 2026
RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement
March 23, 2026
RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET
March 20, 2026
RenovoRx Announces $10 Million at Market Private Placement
March 18, 2026
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum
February 27, 2026
RenovoRx Establishes RenovoCath® Medical Advisory Board
February 12, 2026
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
February 11, 2026
RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting
February 10, 2026
←
Previous Page
1
2
3
Next Page
→